Wealthspire Advisors, LLC Teva Pharmaceutical Industries LTD Transaction History

Wealthspire Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	SELL	$7.2 - $9.47 $72,000 - $94,700	-10,000 Reduced 6.66%	140,123 $1.06 Million
Q1 2023 May 09, 2023	SELL	$8.36 - $11.37 $19,654 - $26,730	-2,351 Reduced 1.54%	150,123 $1.33 Million
Q4 2022 Feb 13, 2023	SELL	$7.95 - $9.48 $537,809 - $641,312	-67,649 Reduced 30.73%	152,474 $1.39 Million
Q3 2022 Nov 14, 2022	BUY	$6.86 - $11.95 $480,200 - $836,500	70,000 Added 46.63%	220,123 $1.78 Million
Q2 2022 Aug 09, 2022	SELL	$7.38 - $10.4 $1.25 Million - $1.77 Million	-170,000 Reduced 53.1%	150,123 $1.13 Million
Q1 2022 May 09, 2022	BUY	$7.33 - $9.39 $258,404 - $331,025	35,253 Added 12.38%	320,123 $3.01 Million
Q4 2021 Feb 14, 2022	BUY	$7.9 - $10.19 $1.13 Million - $1.45 Million	142,519 Added 100.12%	284,870 $2.28 Million
Q3 2021 Nov 15, 2021	BUY	$8.38 - $10.18 $1.19 Million - $1.45 Million	142,351 New	142,351 $1.39 Million
Q1 2019 May 08, 2019	SELL	$15.58 - $20.01 $249 - $320	-16 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$14.59 - $23.84 $233 - $381	16 New	16 $0

624

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Wealthspire Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Wealthspire Advisors, LLC with notifications on news.